Document is current
Any future updates will be listed below
-
Authors
Song, Sisi
Xie, Linjun
Xu, Huayan
Xu, Ke
Fu, Hang
Zhang, Lu
Hou, Ruilai
Tao, Yuhong
Guo, Yingkun
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82120108015, 82102020，82071874，81971586)
Sichuan Province Science and Technology Support Program (2020YJ0029，21ZDYF1967)
- License Information
-
More Information
Article History
Received: 17 July 2023
Accepted: 10 September 2024
First Online: 1 October 2024
Declarations
:
: The study protocol complied with the requirements of the Declaration of Helsinki, was reviewed by the Institutional Review Board of West China Second University Hospital of Sichuan University (Ethics No.: K2019061,30/04/2020), and the clinical trial registration was completed and approved by the China Clinical Trial Registry (Registration No.: ChiCTR2100053084,10/11/2021). Before the cardiac magnetic resonance examination, the investigators explained the purpose of the study, the enrollment procedure, the risks of the CMR examination, the contingency plan for unforeseen events, and the benefits of the study to all children with CKD, children in the normal control group, and their families. The subjects themselves and their guardians were enrolled in the study after agreeing to participate and signing an informed consent form. All patient sensitive information was kept strictly confidential and used only for the purposes of this study.
: Not applicable.
: The authors declare no competing interests.
